|
Orgénesis Inc. (ORGS) Valoración de DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Orgenesis Inc. (ORGS) Bundle
Ya sea que sea un inversionista o analista, esta calculadora DCF (ORGS) es su recurso de referencia para una valoración precisa. Equipado con datos reales de Orgenesis Inc., puede ajustar las previsiones y observar instantáneamente los efectos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 33.3 | 7.7 | 35.5 | 36.0 | .5 | .4 | .4 | .3 | .2 | .2 |
| Revenue Growth, % | 0 | -76.99 | 363.96 | 1.47 | -98.53 | -18.51 | -18.51 | -18.51 | -18.51 | -18.51 |
| EBITDA | -18.9 | -94.2 | -15.7 | -8.3 | -60.7 | -.3 | -.2 | -.2 | -.2 | -.1 |
| EBITDA, % | -56.86 | -1231.14 | -44.27 | -23.05 | -11456.23 | -64.84 | -64.84 | -64.84 | -64.84 | -64.84 |
| Depreciation | 3.8 | 1.4 | 1.9 | 2.0 | 1.6 | .1 | .1 | .1 | .1 | .1 |
| Depreciation, % | 11.44 | 18.75 | 5.25 | 5.49 | 294.34 | 28.19 | 28.19 | 28.19 | 28.19 | 28.19 |
| EBIT | -22.7 | -95.6 | -17.6 | -10.3 | -62.3 | -.3 | -.2 | -.2 | -.2 | -.1 |
| EBIT, % | -68.3 | -1249.9 | -49.52 | -28.54 | -11750.57 | -69.27 | -69.27 | -69.27 | -69.27 | -69.27 |
| Total Cash | 11.4 | 44.9 | 5.5 | 5.3 | .8 | .2 | .2 | .2 | .1 | .1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 2.0 | 3.3 | 15.2 | 36.2 | .1 | .2 | .1 | .1 | .1 | .1 |
| Account Receivables, % | 6.12 | 42.52 | 42.94 | 100.44 | 16.6 | 41.64 | 41.64 | 41.64 | 41.64 | 41.64 |
| Inventories | 2.0 | .2 | .1 | .1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 6.14 | 2.42 | 0.33238 | 0.3331 | 6.42 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 |
| Accounts Payable | 5.5 | 8.6 | 5.2 | 4.4 | 6.6 | .2 | .2 | .1 | .1 | .1 |
| Accounts Payable, % | 16.69 | 113.03 | 14.75 | 12.29 | 1242.26 | 48.75 | 48.75 | 48.75 | 48.75 | 48.75 |
| Capital Expenditure | -12.1 | -1.5 | -7.9 | -12.4 | -2.1 | -.2 | -.1 | -.1 | -.1 | -.1 |
| Capital Expenditure, % | -36.47 | -19.93 | -22.16 | -34.46 | -395.47 | -42.6 | -42.6 | -42.6 | -42.6 | -42.6 |
| Tax Rate, % | 14.1 | 14.1 | 14.1 | 14.1 | 14.1 | 14.1 | 14.1 | 14.1 | 14.1 | 14.1 |
| EBITAT | -23.2 | -94.1 | -17.7 | -10.5 | -53.5 | -.3 | -.2 | -.2 | -.2 | -.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -30.1 | -90.4 | -39.0 | -42.6 | -15.7 | -6.8 | -.3 | -.2 | -.2 | -.2 |
| WACC, % | 10.44 | 10.4 | 10.44 | 10.44 | 10.14 | 10.37 | 10.37 | 10.37 | 10.37 | 10.37 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -6.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | -2 | |||||||||
| Present Terminal Value | -1 | |||||||||
| Enterprise Value | -8 | |||||||||
| Net Debt | 22 | |||||||||
| Equity Value | -30 | |||||||||
| Diluted Shares Outstanding, MM | 29 | |||||||||
| Equity Value Per Share | -1.03 |
What You Will Get
- Real Orgenesis Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Orgenesis’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.
Key Features
- Comprehensive Financial Data: Gain access to precise historical figures and future forecasts for Orgenesis Inc. (ORGS).
- Adjustable Projection Parameters: Modify highlighted fields such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Instant updates for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Visual Dashboard: User-friendly charts and summaries to help you interpret your valuation findings.
- Designed for All Skill Levels: An intuitive layout tailored for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Orgenesis Inc. (ORGS) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Orgenesis Inc. (ORGS)'s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose Orgenesis Inc. (ORGS) Calculator?
- Comprehensive Tool: Offers advanced analytics including DCF, WACC, and financial ratio assessments all in one platform.
- Customizable Inputs: Modify the highlighted cells to explore different financial scenarios.
- Detailed Insights: Automatically computes Orgenesis Inc.’s intrinsic value and Net Present Value.
- Preloaded Data: Features historical and projected data to provide reliable starting points.
- Professional Quality: Perfect for financial analysts, investors, and business advisors.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Orgenesis Inc. (ORGS) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to Orgenesis Inc. (ORGS).
- Consultants: Deliver professional valuation insights on Orgenesis Inc. (ORGS) to clients quickly and accurately.
- Business Owners: Understand how biopharmaceutical companies like Orgenesis Inc. (ORGS) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to Orgenesis Inc. (ORGS).
What the Orgenesis Inc. Template Contains
- Preloaded ORGS Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.